Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Problemi speciali

PDF

Il deficit del gene SHOX come causa di bassa statura

SHOX GENE DEFICIENCY AS THE UNDERLYING CAUSE OF SHORT STATURE

Lorenzo Iughetti1, Sergio Bernasconi2, Emanuela Caruso-Nicoletti3, Francesco Chiarelli4, Alessandro Cicognani5

1 2 3 4 5Clinica Pediatrica, 1Università di Modena e Reggio Emilia, 2Parma, 3Catania, 4Chieti, 5Bologna

Giugno 2011 - pagg. 367 -373

Abstract
SHOX gene (Short Stature Homeobox-containing gene) seems to play an important role in the growth process. Indeed, patients with mutations or deletions of this gene present with variable degrees of stature deficiency that in the most serious cases is accompanied by mesomelic skeletal dysplasia. This characteristic variability is due to the fact that SHOX gene is localized on both sexual chromosomes in a particular area defined as pseudoautosomal region or PAR1 and in normal condition both genes must be present and active. Clinical conditions that fall within SHOX gene alterations include Langer mesomelic dwarfism, Léri-Weill dyschondrosteosis and Turner syndrome. Studies on the SHOX gene alterations have been recently carried out also in patients with idiopathic short stature and the importance of analysing these subjects carefully in order to identify those who might benefit from a growth hormone treatment has been underlined. Indeed, it seems that the GH therapy improves the statures of patients with SHOX gene deficiency, with a significant increase similar to the one obtained in the patients with Turner syndrome.
Bibliografia
1. Reynaud R, Saveanu A, Barlier A, Enjalbert A, Brue T. Pituitary hormone deficiencies due to transcription factor gene alterations. Growth hormone IGF-1 Res 2004;14:422-8 2. Ballabio A, Bardoni B, Carrozzo R, et al. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc Nat Acad Sci 1989;86:10001-5. 3. Ogata T, Matsuo N. Sex chromosome aberrations and stature: deduction of the principal factors involved in the determination of adult height. Hum Genet 1993;91:551-62. 4. Ogata I, Goodfellow P, Petit C, Aya M, Matsuo N. Short stature in a girl with a terminal Xp deletion distal to DXYS15: localisation of a growth gene(s) in the pseudoautosomal region. J Med Genet 1992:29:455-9. 5. Ogata T, Yoshizawa A, Muroya K, et al. Short stature in a girl with partial monosomy of the pseudoautosomal region distal to DXYS15: further evidence for the assignment of the critical region for a pseudoautosomal growth gene(s). J Med Genet 1995;32:831-4. 6. Rao E, Weiss B, Fukami M, et al. FISH-deletion mapping defines a 270-kb short stature critical interval in the pseudoautosomal region PAR1 on human sex chromosomes. Hum Genet 1997;100:236-9. 7. Rao E, Blaschke RJ, Marchini A, Niesler B, Burnett M, Rappold GA. The L�ri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activator. Hum Mol Genet 2001;10:3083-91. 8. Clement-Jones M, Schiller S, Rao E, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000;9:695-702. 9. Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nature Genet 1997;16:54-63. 10. Rappold GA, Fukami M, Niesler B, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab 2002;87:1402-6. 11. Zinn AR, Wei F, Zhang L, et al. Complete SHOX deficiency causes Langer mesomelic dysplasia. Am J Med Genet 2002;110:158-63. 12. Batch J. Turner syndrome in childhood and adolescence. Best Pract Res Clin Endocrinol Metab 1002;16:465-82. 13. L�ri A, Weill J. Une affection congenitale et sym�trique du developpement osseux: la dyschondrosteose. Bull Mem Soc Med Hosp (Paris) 1929;35:1491-4. 14. Madelung V. Die spontane Subluxation der Hand nach vorne. Arch Klin Chir 1878;23:395- 412. 15. Schiller S, Spranger S, Schechinger B, et al. Phenotypic variation and genetic heterogeneity in L�ri-Weill syndrome. Eur J Hum Genet 2000;8:54-62. 16. Fisher E, Scambler P. Human haploinsufficiency- one for sorrow, two for joy. Nat Genet 1994;7:5-7. 17. Ogata T. SHOX: pseudoautosomal homeobox containing gene for short stature and dyschondrosteosis. Growth Horm IGF Res 1999; 9(Suppl. B):53-8. 18. Shears DJ, Vassal HJ, Goodman FR, et al. Mutation and deletion of the pseudoautosomal gene SHOX cause L�ri-Weill dyschondrosteosis. Nat Genet 1998;19:70-3. 19. Belin V, Cusin V, Viot G, et al. SHOX mutations in dyschondrosteosis (L�ri-Weill syndrome). Nat Genet 1998;19:67-9. 20. Calabrese G, Fischetto R, Stuppia L, et al. X/Y translocation in a family with L�ri-Weill dyschondrosteosis. Hum Genet 1999;105:367- 8. 21. Stuppia L, Calabrese G, Borrelli P, et al. Loss of the SHOX gene associated with L�ri-Weill dyschondrosteosis in a 45,X male. J Med Genet 1999;36:711-3. 22. Grigelioniene G, Eklof O, Ivarsson SA, et al. Mutations in short stature homeobox containing gene (SHOX) in dyschondrosteosis but not in hypochondroplasia. Hum Genet 2000;101:145-9. 23. Blaschke RJ, Rappold GA. SHOX in short stature syndromes. Horm Res 2001;55(1):21-3. 24. Falcinelli C, Iughetti L, Percesepe A, et al. SHOX point mutations and deletions in L�ri- Weill dyschondrosteosis. J Med Genet 2002; 39:E33. 25. Brailsford JF. Dystrophies of the skeleton. Brit J Radiol 1935;8:533-69. 26. Book JA. A clinical and genetical study of disturbed skeletal growth (chondrohypoplasia). Hereditas 1950;36:161-80. 27. Langer LO Jr. Mesomelic dwarfism of the hypoplastic ulna, fibula, mandible type. Radiology 1967;89:654-60. 28. Blockey NJ, Lawrie JH. An unusual symmetrical distal limb deformity in siblings. J Bone Joint Surg Br 1963;45:745-7. 29. Carter AR, Currey HL. Dyschondrosteosis (mesomelic dwarfism) - a family history. Br J Radiol 1974;47:634-40. 30. Espiritu C, Chen H, Woolley PV Jr. Mesomelic dwarfism as the homozygous expression of dyschondrosteosis. Am J Dis Child 1975;129:375-7. 31. Lisker R, Gamboa I, Hernandez J. Dyschondrosteosis. A Mexican family with two affected males. Clin Genet 1972;3:154-7. 32. Fryns JP, Van Den Berghe H. Langer type of mesomelic dwarfism as the possible homozygous expression of dyschondrosteosis. Hum Genet 1979;46:21-7. 33. Robertson SP, Shears DJ, Oei P, et al. Homozygous deletion of SHOX in a mentally retarded male with Langer mesomelic dysplasia. J Med Genet 2000;37:959-64. 34. Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566. 35. Rosenfeld R, Tesch L, Rodriguez-Rigau L. Recommendation for diagnosis, treatment and management of individuals with Turner syndrome. Endocrinology 1996;4:351-8. 36. Kosko T, Muroya K, Nagai T, et al. Skeletal features and growth patterns in 14 patients with hyploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab 1999;84:4613-21. 37. Ranke MB, Sanger P. Turner�s syndrome. Lancet 2001;358:309-14. 38. Ogata T, Tyler-Smith C, Purvis-Smith, Turner G. Chromosomal localization of a gene(s) for Turner stigmata on Yp. J Med Genet 1993; 30:918-22. 39. Binder G, Schwarze CP, Ranke MB. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone. J CIin Endocrinol Metab 2000:85:245-9. 40. Morizio E, Stuppia L, Gatta V, et al. Deletion of the SHOX gene in patients with short stature of unknown cause. Am J Med Genet A 2003;119:293-6. 41. Stuppia L, Calabrese G, Gatta V, et al. SHOX mutations detected by FISH and direct sequencing in patients with short stature. J Med Genet 2003;40:E11. 42. Blum WF, Crowe BJ, Quigley CA, et al. Growth hormone is effective in treatment of short stature associated with short stature homeobox- containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 2007;92:219-28. 43. Blum WF, Cao D, Hesse V, et al. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res 2009;71:167-72.

Corrispondenza: iughetti.lorenzo@unimore.it